We are live on ! Find out more

ALPS

ALPS Group Inc

ALPS

Market cap $63.2M

0.3800 USD

0.0000

0%

At close Updated Sep 4, 4:00 PM EDT

1 day

0%

5 days

1.39%

1 month

-4.14%

3 months

-45.74%

6 months

-58.38%

Year to date

-58.29%

1 year

-85.16%

5 years

-85.16%

10 years

-85.16%

About: ALPS Group Inc is an investment holding company involved in research and development, including stem cell and biotechnology-related business, and investing and managing businesses such as health and beauty centres and medical centres. The Company operates through Medical and Wellness, Life Science and Others segments. Medical and Wellness generates maximum revenue from non-surgical aesthetic services, surgical aesthetic services, medical consultation, health screenings, cellular therapy and research, and COVID-19 testing. Life Science provides whole-genome sequencing and pharmacogenomics, while Others comprises investment holding and provision of management services. The Company generates revenue in Malaysia.

Employees: 89

Healthcare Biotechnology

News

Positive

Neutral

Negative

Sentiment 3-Months

Positive 25%

Neutral 75%

Negative 0%

ALPS Corporation Goes Live on OneShield Market Solutions to Power Lawyers' Professional Liability Operations for LawyerCare

MARLBOROUGH, Mass.--(BUSINESS WIRE)-- #AI--OneShield, a provider of modern, AI powered systems for commercial property & specialty insurers and MGAs, today announced that ALPS Property & Casualty Insurance Company (ALPS), the nation's largest direct writer of lawyers' malpractice insurance, has gone live on OneShield Market Solutions (OMS) for policy administration of its LawyerCare lawyers' professional liability (LPL) program. The implementation positions ALPS to operate its recently acquir.

ALPS Corporation Goes Live on OneShield Market Solutions to Power Lawyers' Professional Liability Operations for LawyerCare

Alps Group Inc Reports Fiscal Year 2026 Financial Results and Provides Business Update

Revenue Grew 44% to $4.9 Million, Led by Continued Growth Across Cellular Therapy, Medical Testing, Laboratory and Aesthetics Beauty Services, and Healthcare Products

Alps Group Inc Reports Fiscal Year 2026 Financial Results and Provides Business Update

ALPS Ties Fund Growth to Distribution Discipline

Running a $22 billion ETF lineup with a distribution team far smaller than the largest issuers means every new fund has to earn its place on the shelf. Key Takeaways: A lean distribution team requires deliberate choices about new product launches.

ALPS Ties Fund Growth to Distribution Discipline

Small Cap Quality Over Size: Why ALPS OUSM Deserves a Look

When evaluating small-cap equity exposure, it's easy to gravitate towards the iShares Russell 2000 ETF (IWM) given its $82 billion in assets and 0.19% expense ratio. Yet, a closer look at another fund, the ALPS O'Shares U.S. Small-Cap Quality Dividend ETF (OUSM), reveals a fundamentally sound structural design that warrants closer attention.

Small Cap Quality Over Size: Why ALPS OUSM Deserves a Look

Rosenbluth Discusses Thematics & RAFI Acquisition on Schwab Network

TMX VettaFi Head of Research Todd Rosenbluth discusses thematic ETFs and the implications of VettaFi's acquisition of RAFI Indices on Schwab Network. VettaFi's RAFI Indices Acquisition and Fundamental Shift On June 11, VettaFi announced the acquisition of RAFI Indices, a deal expected to close in the coming weeks.

Rosenbluth Discusses Thematics & RAFI Acquisition on Schwab Network

Alps Group Inc Launches Patient-Derived Organoid Program to Advance Personalized Cancer Care in Southeast Asia

Agreement Marks Company's Expansion into Precision Oncology Testing, with the Goal of Establishing Malaysia's First Clinically Validated PDO Platform Agreement Marks Company's Expansion into Precision Oncology Testing, with the Goal of Establishing Malaysia's First Clinically Validated PDO Platform

Alps Group Inc Launches Patient-Derived Organoid Program to Advance Personalized Cancer Care in Southeast Asia

Zacks Investment Research

ETFs for Investors Seeking Balance Amid Ceasefire Optimism

Markets rally on ceasefire hopes, but should investors chase the headlines? ETFs can offer a balanced approach in a headline-driven market.

ETFs for Investors Seeking Balance Amid Ceasefire Optimism

Alps Group Inc Expands MyGenome Accreditation to Include Whole Genome Sequencing Under MS ISO 15189:2022

MyGenome Joins a Limited Number of Southeast Asian Laboratories Delivering WGS Under Internationally Recognized Clinical Standards, Strengthening its Position in Southeast Asian Genomics MyGenome Joins a Limited Number of Southeast Asian Laboratories Delivering WGS Under Internationally Recognized Clinical Standards, Strengthening its Position in Southeast Asian Genomics

Alps Group Inc Expands MyGenome Accreditation to Include Whole Genome Sequencing Under MS ISO 15189:2022

Zacks Investment Research

Love the AI Story but Hate the Concentration Risk? Consider ETFs

AI is driving markets higher, but a handful of stocks are doing most of the heavy lifting. These ETFs offer a more balanced way to play the trend.

Love the AI Story but Hate the Concentration Risk? Consider ETFs

Zacks Investment Research

Tech-Heavy & Anxious? Pick ETFs to Diversify Beyond the AI Bet

The AI trade continues to power markets, but rising concentration risks and volatile sentiment are making diversification increasingly important. Staying diversified with ETFs may be the smartest long-term move.

Tech-Heavy & Anxious? Pick ETFs to Diversify Beyond the AI Bet

See News Rankings

Price charts implemented using Lightweight Charts™